Quantitative Angiogenesis Assays in vivo – A Review Jurjees HasanS.D. ShnyderG.C. Jayson OriginalPaper Pages: 1 - 16
Eph Receptor Tyrosine Kinases in Angiogenesis: From Development to Disease Dana M. Brantley-SiedersJin Chen OriginalPaper Pages: 17 - 28
Circulating Basic Fibroblast Growth Factor is Partly Derived from the Tumour in Patients with Colon, Cervical and Ovarian Cancer R. SalgadoI. BenoyL. Dirix OriginalPaper Pages: 29 - 32
Early Inducible Nitric Oxide Synthase 2 (NOS 2) Activity Enhances Ischaemic Skin Flap Survival Sunao FurutaPeter VadivelooGeraldine Mitchell OriginalPaper Pages: 33 - 43
Different Mechanisms Lead to the Angiogenic Process Induced by Three Adenocarcinoma Cell Lines Lilia E. DavelLaura RimmaudoMaría Elena Sales OriginalPaper Pages: 45 - 51
Glutathione S-Transferase Genotype GSTM1 as a Predictor of Elevated Angiogenic Phenotype in Patients with Early Onset Breast Cancer Rui MedeirosRaquel SoaresCarlos Lopes OriginalPaper Pages: 53 - 58
Activated Neu/ErbB-2 Induces Expression of the Vascular Endothelial Growth Factor Gene by Functional Activation of the Transcription Factor Sp 1 Günter FinkenzellerKarin WeindelDieter Marmé OriginalPaper Pages: 59 - 68
Angiogenesis Inhibition by Angiostatin, Endostatin and TNP-470 Prevents Cyclophosphamide Induced Cystitis Wolf-Dietrich BeeckenTobias EnglKevin Camphausen OriginalPaper Pages: 69 - 73
Inhibition of Angiogenesis by Aβ Peptides Daniel ParisKirk TownsendMichael Mullan OriginalPaper Pages: 75 - 85